Literature DB >> 9794738

White-coat hypertension: a selection bias? Harvest Study Investigators. Hypertension and Ambulatory Recording Venetia Study.

P Palatini1, F Dorigatti, E Roman, P Giovinazzo, D Piccolo, G De Venuto, M Mattarei, E Cozzutti, S Gregori, P Mormino, A C Pessina.   

Abstract

BACKGROUND: Results of several studies have shown that subjects with white-coat hypertension (WCH) have more target-organ damage than do normotensive controls with similar ambulatory blood pressures.
OBJECTIVE: To investigate whether this is due to a selection bias.
SETTING: Seventeen hypertension clinics in northeast Italy. MAIN OUTCOME MEASURES: Echocardiographic data in relation to WCH status. PATIENTS AND METHODS: Mild hypertensive subjects from the HARVEST (n = 565) who underwent two ambulatory blood pressure monitorings 3 months apart and M-mode echocardiography, and 95 normotensive control subjects.
RESULTS: From first ambulatory monitoring, 90 hypertensive subjects were classified as having WCH (mean daytime blood pressure < 130/80 mmHg). Their 24 h blood pressure was similar to that of the normotensive subjects, but their left ventricular mass index was greater. From second ambulatory monitoring, only 38 of the 90 subjects still had WCH, whereas 24 h blood pressure in the other 52 had risen beyond the limit of WCH. Left ventricular mass index (89.2 +/- 2.4 g/m2), wall thickness (18.1 +/- 0.3 mm), and relative wall thickness (0.359 +/- 0.006%) of the 38 subjects with WCH at both recordings were still greater than those of the normotensive subjects (82.4 +/- 1.5 g/m2, P = 0.02; 17.2 +/- 0.2 mm, P = 0.002; and 0.337 +/- 0.004%, P = 0.025) and similar to those of the 52 subjects who no longer had WCH (88.5 +/- 2.0 g/m2, 18.7 +/- 0.2 mm, and 0.375 +/- 0.005%, all NS).
CONCLUSIONS: Owing to regression toward the mean, over 50% of the subjects with WCH could no longer be classified as such from repeated ambulatory monitoring, indicating that the current diagnosis of WCH is subject to selection bias. Cardiac remodeling was present also in the subjects confirmed to have WCH by repeated blood pressure recording, suggesting that the effect of WCH has an actual impact on target organs.

Entities:  

Mesh:

Year:  1998        PMID: 9794738     DOI: 10.1097/00004872-199816070-00011

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  11 in total

1.  Measurement and interpretation of blood pressure.

Authors:  C D Goonasekera; M J Dillon
Journal:  Arch Dis Child       Date:  2000-03       Impact factor: 3.791

2.  Contemporary management of refractory hypertension.

Authors:  A B Alper; D A Calhoun
Journal:  Curr Hypertens Rep       Date:  1999-10       Impact factor: 5.369

Review 3.  Importance of various methods of blood pressure measurement in clinical trials.

Authors:  P Palatini
Journal:  Curr Hypertens Rep       Date:  2000-08       Impact factor: 5.369

4.  Relationship between GFR and albuminuria in stage 1 hypertension.

Authors:  Paolo Palatini; Lucio Mos; Pierferruccio Ballerini; Adriano Mazzer; Francesca Saladini; Alessandra Bortolazzi; Susanna Cozzio; Edoardo Casiglia
Journal:  Clin J Am Soc Nephrol       Date:  2012-09-27       Impact factor: 8.237

Review 5.  Resistant hypertension.

Authors:  David A Calhoun; Mohammad A Zaman; Mari K Nishizaka
Journal:  Curr Hypertens Rep       Date:  2002-06       Impact factor: 5.369

Review 6.  Treatment of white coat hypertension.

Authors:  S G Chrysant
Journal:  Curr Hypertens Rep       Date:  2000-08       Impact factor: 5.369

7.  Applying the 2005 Canadian Hypertension Education Program recommendations: 1. Diagnosis of hypertension.

Authors:  Peter Bolli; Martin Myers; Donald McKay
Journal:  CMAJ       Date:  2005-08-30       Impact factor: 8.262

Review 8.  White Coat Hypertension: to Treat or Not to Treat?

Authors:  Cesare Cuspidi; Carla Sala; Guido Grassi; Giuseppe Mancia
Journal:  Curr Hypertens Rep       Date:  2016-11       Impact factor: 5.369

9.  Labile hypertension: lessons to be learned from musical improvisation.

Authors:  Christopher D Azzara; Mark W Nickels; John D Bisognano
Journal:  J Clin Hypertens (Greenwich)       Date:  2009-03       Impact factor: 3.738

10.  Enhanced Risk of Carotid Atherosclerosis Associated With White-Coat Hypertension.

Authors:  Cesare Cuspidi; Marijana Tadic; Carla Sala
Journal:  J Clin Hypertens (Greenwich)       Date:  2016-08-02       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.